Tectonic Therapeutic Inc.

NASDAQ: TECX · Real-Time Price · USD
23.75
-0.72 (-2.94%)
At close: Aug 15, 2025, 1:07 PM

Tectonic Therapeutic Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
1.65M 617K 4.17M 1.4M
Gross Profit
-1.65M -617K -4.17M -1.4M
Operating Income
-58.02M -44.65M -105.43M -118.84M
Interest Income
4.26M 581K 149K n/a
Pretax Income
-57.98M -42.82M -105.89M -119.13M
Net Income
-57.98M -42.82M -105.89M -119.13M
Selling & General & Admin
15.01M 7.68M 33.25M 35.73M
Research & Development
41.36M 36.97M 68.02M 81.72M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
56.37M 44.65M 101.27M 117.44M
Interest Expense
107K 152K 144K 224K
Selling & Marketing Expenses
n/a n/a 26.07M 31.09M
Cost & Expenses
-58.02M 44.65M 32.83M 15.61M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
8.49M 3.69M 3.64M 3.57M
Shares Outstanding (Diluted)
8.49M 3.71M 3.64M 3.57M
EPS (Basic)
-6.83 -11.59 -29.05 -33.36
EPS (Diluted)
-6.83 -11.53 -29.05 -33.36
EBITDA
-56.23M -41.19M -101.42M -117.5M
EBIT
-57.88M -42.67M -105.59M -118.9M
Depreciation & Amortization
1.65M 1.48M 4.17M 1.4M